Kenvue Inc (KVUE) - Sof foyda bo'yicha sotuv rentabelligi

Kenvue Inc - KVUE emitenti grafik logotipi

Kenvue Inc. ilmiy formulalar va raqamli parvarishni ishlab chiqish orqali iste'molchilar salomatligi segmentida ustunlikka ega. Sof realizatsiya marjasi barqarorlikni namoyish etmoqda, joriy daraja 10.90 ni tashkil etadi, bu esa haddan tashqari qimmat baholangan aksiyalarni sotib olishdan qochishga yordam beradi. Samarali omborlar tarmig'i mahsulotlar yetishmovchiligini bartaraf etadi, garchi geosiyosat va inflyatsiya aktivlar qiymatini pasaytirish hamda iste'molchilarning arzonroq muqobillarga o'tishi xavflarini tug'dirsa-da.

KVUE: Kenvue Health Sotuvning sof marjinal rentabelligi 21.02.2024 - 14.11.2026

Kenvue Corp (KVUE) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Kenvue Inc.
Kenvue Inc tayyor mahsulotlari

Investitsiya xatarlarini minimallashtirish uchun Kenvue Inc. (KVUE) har bir dollar daromadning sof foyda ulushi orqali xarajatlarni boshqarish samaradorligini baholab, bozor shovqinlarini filtrlashi lozim. GURU.Markets platformasida sof foyda marjasi tendentsiyasini tahlil qilib, investor Tylenol va Listerine brendlarining ustunligi kompaniyaga inflyatsiyani iste'molchilarga yuklash imkonini berishini, bu esa yuqori operatsion chidamlilik va fundamental biznes ishonchliligini ta'minlashini ko'radi.

Muhim raqobatchilar

HLN: Sotuvning sof marjinal rentabelligi|Verona Pharma PLC - Sof foyda normasi|Sof marja Jyong Biotech Ltd|Sotuvning sof marjinal rentabelligi Ligand Corp|Sotuvning sof marjinal rentabelligi AMRX|Kompaniya sotuv marjasi Perrigo Company plc|Sotuvning sof marjinal rentabelligi ALVO (Alvotech Biopharmaceuticals)|LQDA: Sotuvning sof rentabelligi|Galapagos N.V. - Sotuvning sof marjinal rentabelligi|ANIP - Sotuvning sof marjinal rentabelligi|MNKD: Sotuvning sof marjinal rentabelligi|amphastar.com (AMPH) - Sotuvning sof marjinal rentabelligi|PCRX (Pacira Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ARS Pharmaceuticals, Inc. (SPRY)|Sotuvning sof marjinal rentabelligi TBPH|AQST (Aquestive Therapeutics) - Sof foyda normasi|scPharmaceuticals, Inc. - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi TECX|tonixpharma.com - Sotuvning sof marjinal rentabelligi|Sof foyda normasi SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi BioHarvest|Sof foyda bo'yicha sotuv rentabelligi EXOZ|Sof foyda bo'yicha sotuv rentabelligi Oramed Pharmaceuticals (ORMP)|Sof foyda bo'yicha sotuv rentabelligi ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi ABVC (ABVC BioPharma Inc)|CPIX - Sof foyda bo'yicha sotuv rentabelligi|Quantum BioPharma Corp - Sotuvning sof marjinal rentabelligi|FGEN (fibrogen.com) - Sotuvning sof rentabelligi|TELO (Telomir Pharmaceuticals) - Sof foyda bo'yicha sotuv rentabelligi|Rani Therapeutics Holdings - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi SNYR|Sof marja rallybio.com RLYB|Sotuvning sof marjinal rentabelligi LEXX|PULM (Pulmatrix, Inc.) - Sof foyda normasi|Pheton Holdings - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Aptorum Group Limited APM|LYRA: Sof foyda bo'yicha sotuv rentabelligi|IBO: Sof marja|TNFA: Sotuvning sof marjinal rentabelligi|YCBD: Kompaniyaning sof rentabelligi|Sof marja PainReform Ltd|CYTO (altamiratherapeutics.com) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi LIPO|OPTN - Sof marja|Sof marja pieris.com PIRS|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma